Concepedia

Anders Källén

AK

Statistics

Publications

7

Citations

397

H-Index

7

Active since

1989

Affiliations

AstraZeneca (Sweden)(Current)

Anders Källén is an author at AstraZeneca (Sweden) specializing in bronchodilator therapy, pharmacy, and asthma pharmacotherapy.

Publications per year

1989–2012

7

Publications

7

Pharmacokinetics and systemic activity of fluticasone via Diskus<sup>®</sup> and pMDI, and of budesonide via Turbuhaler<sup>®</sup>

Lars Thorsson, Staffan Edsbäcker, Anders Källén et al. · British Journal of Clinical Pharmacology · 2001 · 167 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Increasing Doses of Inhaled Corticosteroids Compared to Adding Long-Acting Inhaled β 2 -Agonists in Achieving Asthma Control

Paul M. O’Byrne, Ian Naya, Anders Källén et al. · CHEST Journal · 2008 · 69 citations

Pharmacy, Pharmacology, Pharmacotherapy +12

Effects of budesonide by means of the Turbuhaler on the hypothalmic-pituitary-adrenal axis in asthmatic subjects: A dose-response study☆☆☆★★★

Donald Aaronson, Harold B. Kaiser, Robert J. Dockhorn et al. · Journal of Allergy and Clinical Immunology · 1998 · 62 citations · Full text

Medicine, Endocrinology, Pharmacology +15

Repeated intranasal TLR7 stimulation reduces allergen responsiveness in allergic rhinitis

Lennart Greiff, Anders Cervin, Cecilia Ahlström‐Emanuelsson et al. · Respiratory Research · 2012 · 51 citations · Full text

Life Sciences, Immunology, Otolaryngology +14

Treatment-By-Center Interaction: What is The Issue?

Anders Källén · Drug Information Journal · 1997 · 23 citations

Medicine, Psychiatry, Psychotherapy +4

1–5 of 7